TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 78 filers reported holding TRANSLATE BIO INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $834,000 | +89.1% | 30,316 | +13.3% | 0.00% | – |
| Q1 2021 | $441,000 | +27.5% | 26,759 | +42.6% | 0.00% | – |
| Q4 2020 | $346,000 | +130.7% | 18,767 | +70.6% | 0.00% | – |
| Q3 2020 | $150,000 | -29.6% | 11,000 | -7.4% | 0.00% | – |
| Q2 2020 | $213,000 | +97.2% | 11,884 | +10.3% | 0.00% | – |
| Q1 2020 | $108,000 | +535.3% | 10,772 | +420.4% | 0.00% | – |
| Q4 2019 | $17,000 | +183.3% | 2,070 | +245.0% | 0.00% | – |
| Q3 2019 | $6,000 | -96.1% | 600 | -96.0% | 0.00% | – |
| Q1 2019 | $153,000 | +35.4% | 15,000 | 0.0% | 0.00% | – |
| Q4 2018 | $113,000 | +8.7% | 15,000 | +43.7% | 0.00% | – |
| Q3 2018 | $104,000 | – | 10,439 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |